Subtitle
Cost effectiveness
Subtitle
Cost effectiveness
Proto therapy Time
February 2016
Executive summary
A systematic review of the cost-effectiveness of proton therapy found that proton therapy was a cost-effective option for several pediatric brain tumors, selected left-sided breast cancer, selected head and neck cancer and locoregionally advanced non-small cell lung cancer.
Key content topics
Top cancer treatments
Related contents
Webinar
IBA Power Up Event at ASTRO 2023
The inevitability of Proton Therapy: Embracing Proton Therapy for Future-Proof Radiotherapy
James
Metz
Kosj
Yamoah
Craig
Stevens
Fen
Xia
Webinar
February 7, 2023
Where is proton therapy headed?
Steven
Frank
Ramesh
Rengan
Craig
Stevens
Jennifer
Maggiore
Shannon
MacDonald
Frederic
Genin
Webinar
February 7, 2023
Emerging Proton Therapy Indication: Lung Cancer
Joe
Chang
Webinar
February 6, 2023
How to Build and Operate a Proton Therapy Facility
Steven
Frank
Darrin
Kistler
James
Metz
Matt
Palmer
Frederic
Genin
Jonathan
Weinbach
Webinar
April 23, 2022
Proton Therapy for Central Nervous System & Base of Skull Tumors
Helen
Shih
Webinar
April 23, 2022
Pediatric Proton Therapy: Indications and Patient Selection
Matthew
Hall
Webinar
April 23, 2022
A Journey to DynamicARC: recent breakthrough and future roadmap
Xuanfeng (Leo)
Ding
Proton Therapy Publication
July 2022
30 years of ocular PT, the Nice view.
User meeting
Friday, June 3, 2022
Clinical outcome: what's new, what's ongoing?
Sofie
Gillis
Barbara
Jereczek
Michael
Chuong
Rohan L.
Deraniyagala
Please connect to access this resource and get a more personalized Campus experience
Login